MolecuLight Showcases Cutting-Edge Bacterial Imaging for Burns at 2025 American Burn Association Meeting

Introduction

MolecuLight Inc., a leading innovator in point-of-care fluorescence imaging, is set to make a significant impact at the 2025 American Burn Association (ABA) annual meeting in Phoenix, Arizona. Scheduled from April 8 to 11, this event will feature MolecuLight's revolutionary imaging technology, which allows immediate and non-invasive visualization of bacteria in wounds. This advancement is particularly crucial for enhancing the treatment and management of burn injuries.

Clinical Breakthroughs

During the event, Dr. Erik Hanson-Viana, a distinguished plastic and reconstructive surgeon from Hospital Angeles in Mexico City, will present significant findings on April 9 at 11:45 AM. His presentation, titled "Fluorescence Imaging-Guided Sampling Provides More Accurate and Actionable Microbiology Compared to the Levine Technique," will delve into the transformative effects of MolecuLight's technology on the reconstruction of extensive burn injuries. This method promises an optimal timing and selection of graft sites, surpassing traditional techniques.

Pioneering Research

Another highlight of the conference will be the poster presentation by Dr. Carlos Daniel Torres García, who will showcase his award-winning research titled "Bacterial Fluorescence Signals Are Associated with Dermal Regeneration Template Infections in Burn Patients" on April 9 at 12:30 PM. This groundbreaking work emphasizes the correlation between bacterial loads detected by MolecuLight and the failure of cellular tissue products in burn reconstructions. Dr. García's research has gained international recognition, even securing second place for the best scientific protocol at the 55th Annual Mexican National Congress of Plastic Surgery earlier this year.

Hands-On Demonstrations

MolecuLight will also provide live demonstrations of its imaging systems at Booth #626 throughout the conference. Attendees will have the unique opportunity to engage directly with Dr. Hanson-Viana and MolecuLight representatives, witnessing firsthand the capabilities of the MolecuLight iX® and MolecuLight DX™ systems. These advanced devices deliver real-time information regarding biological load, pivotal for clinical decision-making to enhance burn treatment.

Dr. Hanson-Viana expresses the significant potential of MolecuLight's technology: "The ability to visualize bacteria in real time will revolutionize the approach to burn injury reconstruction. MolecuLight provides immediate, actionable data that facilitates more precise procedures, ultimately resulting in improved reconstructive outcomes. My research will illustrate the clear advantages of MolecuLight-guided sampling over traditional methods, and I look forward to sharing these insights with my colleagues at the ABA meeting."

Conclusion

With its advanced fluorescence imaging technology, MolecuLight aims to transform burn care practices. The upcoming ABA annual meeting presents a vital platform for introducing this innovation to healthcare professionals. As the field of wound care continues to evolve, technologies like those provided by MolecuLight will undoubtedly play a key role in improving patient outcomes and setting new standards in burn treatment.

For more information about MolecuLight and their groundbreaking imaging systems, you can visit MolecuLight's website.